EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PEDV-spike-protein-expressing mRNA vaccine protects piglets against PEDV challenge

Yongxiang Zhao iD, Baochao Fan iD, Xu Song, Jie Gao, Rongli Guo, Cheng Yi, Zhaoming He, Hongpeng Hu, Jianhao Jiang, Lixiang Zhao iD, Tianyi Zhong iD, Bin Li iD

mBio · 14.02.2024 · 15 (2)

DOI: 10.1128/mbio.02958-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 14.02.2024. Verfasst von Yongxiang Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing, China. Hauptthemen laut MEDLINE: Porcine epidemic diarrhea virus, Viral Vaccines, Coronavirus Infections, Swine Diseases. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), MOST | National Key Research and Development Program of China (NKPs), Jiangsu Agricultural Science and Technology Innovation Fund (JASTIF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porcine epidemic diarrhea virus (PEDV) continues to harm the global swine industry. It is important to develop a highly effective vaccine to control PEDV infection. Here, we report a PEDV spike (S) mRNA vaccine that primes a potent antibody response and antigen-specific T-cell responses in immunized piglets. Active and passive immunization can protect piglets against PED following the virus challenge. This study highlights the efficiency of the PEDV-S mRNA vaccine and represents a viable approach for developing an efficient PEDV vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Porcine epidemic diarrhea virusViral VaccinesCoronavirus InfectionsSwine DiseasesAnimalsSwineFemaleMiceAntibodies, ViralmRNA VaccinesSpike Glycoprotein, CoronavirusDiarrheaRNA, Messenger

Stichwörter der Autor:innen

PEDVmRNA vaccinepigletsprotective immunityspike protein

Substanzen

Antibodies, ViralmRNA VaccinesViral VaccinesSpike Glycoprotein, CoronavirusRNA, Messenger

Autor:innen und Institutionen

  • Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing, China.
  • Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Nanjing, China.
  • Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology, Nanjing, China.
  • Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, China.
  • GuoTai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou, China.
  • Suzhou Huiliao Biomedical Technology Co. Ltd., Suzhou, China.

ORCID-Profile: Yongxiang Zhao, Baochao Fan, Lixiang Zhao, Tianyi Zhong, Bin Li

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • MOST | National Key Research and Development Program of China (NKPs)
  • Jiangsu Agricultural Science and Technology Innovation Fund (JASTIF)

Zitieren

APA

Zhao, Y., Fan, B., Song, X., Gao, J., Guo, R., Yi, C., He, Z., Hu, H., Jiang, J., Zhao, L., Zhong, T., & Li, B. (2024). PEDV-spike-protein-expressing mRNA vaccine protects piglets against PEDV challenge. mBio, 15(2). https://doi.org/10.1128/mbio.02958-23

Vancouver

Zhao Y, Fan B, Song X, Gao J, Guo R, Yi C, et al. PEDV-spike-protein-expressing mRNA vaccine protects piglets against PEDV challenge. mBio. 2024;15(2). doi:10.1128/mbio.02958-23

BibTeX
@article{Zhao2024,
  author = {Zhao, Yongxiang and Fan, Baochao and Song, Xu and Gao, Jie and Guo, Rongli and Yi, Cheng and He, Zhaoming and Hu, Hongpeng and Jiang, Jianhao and Zhao, Lixiang and Zhong, Tianyi and Li, Bin},
  title = {PEDV-spike-protein-expressing mRNA vaccine protects piglets against PEDV challenge},
  journal = {mBio},
  year = {2024},
  volume = {15},
  number = {2},
  doi = {10.1128/mbio.02958-23}
}
Kostenlos starten →